Entecavir

NDC 65862-841 · Aurobindo Pharma Limited

Generic nameEntecavir

Dosage formTABLET

RouteORAL

Active ingredient(s)ENTECAVIR

Strength.5 mg/1

Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]

Marketing categoryANDA

Packages

65862-841-30 — 1 BOTTLE in 1 CARTON (65862-841-30) / 30 TABLET in 1 BOTTLE

65862-841-90 — 1 BOTTLE in 1 CARTON (65862-841-90) / 90 TABLET in 1 BOTTLE

65862-841-99 — 1 BOTTLE in 1 CARTON (65862-841-99) / 1000 TABLET in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0003-1614 — entecavir, 16714-717 — ENTECAVIR, 16714-718 — ENTECAVIR, 42291-261 — Entecavir, 42806-658 — Entecavir, 42806-659 — Entecavir, 50771-013 — entecavir, 50771-014 — entecavir, 51407-589 — Entecavir, 60687-216 — Entecavir, 61442-311 — Entecavir, 65162-446 — Entecavir, 65162-449 — Entecavir, 65862-842 — Entecavir, 68382-920 — Entecavir, 68382-921 — Entecavir, 69097-425 — ENTECAVIR, 69097-426 — ENTECAVIR, 70771-1019 — Entecavir, 70771-1020 — Entecavir, +2 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.